Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review

Abstract

Juxtaglomerular cell tumors (JGCTs) or reninoma are rare kidney tumors leading to secondary hypertension, and the non-specific clinical manifestations bring about challenges to the diagnosis. This study is to summarize the clinical features, laboratory findings, and treatment of JGCTs. The PubMed, EMBASE database, and manual search were utilized to find all cases, and 158 reports containing 261 patients were identified. Data on patients’ demographics, clinical features, diagnostic methods, and treatment options were collected and analyzed. JGCTs occurred predominantly in female patients (female to male ratio, 2.1:1). The median age of patients was 25 years (IQR:18–34 years). Hypertension (97.24%) was the cardinal manifestation. Hypokalemia was reported in 78.71% (159/202) of subjects, and normal serum potassium accounted for 20.79% (42/202). In cases with assessed plasma renin activity (PRA) levels, the median PRA was 7.89 times the upper limit of normal (IQR:3.58–14.41), and 3.82% (5/131) of cases in the normal range. Tumors were detected in 97.8% (175/179) computed tomography (CT), 94.7% (72/76) magnetic resonance imaging (MRI), and 81.5% (110/135) ultrasound, respectively. For 250/261 patients undergoing surgical procedures, 89.14% (197/221), 94.94% (150/158), and 100% (131/131) of patients were restored to normal blood pressure, PRA, and serum potassium, respectively. JGCTs are commonly associated with hypertension, hypokalemia, and hyperreninemia, whereas patients with normotension, normokalemia, and PRA should be systematically pursued after drug-elution lasting for 2 weeks. CT and MRI are more sensitive imaging diagnostic methods. The blood pressure and biochemical parameters of most patients returned to normal after surgery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Robertson PW, Klidjian A, Harding LK, Walters G, Lee MR, Robb-Smith AH. Hypertension due to a renin-secreting renal tumour. Am J Med. 1967;43:963–76.

    Article  CAS  PubMed  Google Scholar 

  2. Jiang S, Yang Y, Wu R, Yang Q, Zhang C, Tang Y, et al. Characterization and management of juxtaglomerular cell tumor: analysis of 9 cases and literature review. Balk Med J. 2020;37:287–90.

    CAS  Google Scholar 

  3. Osawa S, Hosokawa Y, Soda T, Yasuda T, Kaneto H, Kitamura T, et al. Juxtaglomerular cell tumor that was preoperatively diagnosed using selective renal venous sampling. Intern Med. 2013;52:1937–42.

    Article  PubMed  Google Scholar 

  4. Hanna W, Tepperman B, Logan AG, Robinette MA, Colapinto R, Phillips MJ. Juxtaglomerular cell tumour (reninoma) with paroxysmal hypertension. Can Med Assoc J. 1979;120:957–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Min KO, Kwon HJ, Ahn SJ, Chang SA, Chang YS, Bang BK, et al. Juxtaglomerular cell tumor of the kidney: a case report. J Korean Med Sci. 2001;16:233–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jo HA, Kwak C, Chul Moon K, Lee JH, Hwan Park J, Lee S, et al. A case of reninoma with variant angina. Kidney Res Clin Pract. 2014;33:106–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shao L, Manalang M, Cooley L. Juxtaglomerular cell tumor in an 8-year-old girl. Pediatr Blood Cancer. 2008;50:406–9.

    Article  PubMed  Google Scholar 

  8. Lumbers ER, Pringle KG. Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol. 2014;306:R91–101.

    Article  CAS  PubMed  Google Scholar 

  9. Hayes AG, Stowasser M, Umapathysivam MM, Falhammar H, Torpy DJ. Approach to the patient: reninoma. J Clin Endocrinol Metab. 2023. https://doi.org/10.1210/clinem/dgad516.

  10. Mimran A, Leckie BJ, Fourcade JC, Baldet P, Navratil H, Barjon P. Blood pressure, renin-angiotensin system and urinary kallikrein in a case of juxtaglomerular cell tumor. Am J Med. 1978;65:527–36.

    Article  CAS  PubMed  Google Scholar 

  11. Henderson NL, Mason RC. Juxtaglomerular cell tumor in pregnancy. Obstet Gynecol. 2001;98:943–5.

    CAS  PubMed  Google Scholar 

  12. Ren G, Yu X, Li Y, Shi S, Wang L, Ye H. Juxtaglomerular cell tumor of the kidney: a clinicopathological analysis of five cases. Chin Med J (Engl). 2003;116:1789–92.

    PubMed  Google Scholar 

  13. Libório AB, de Oliveira Marques F, Testagrossa L, Leite CA, Leitão AA, Praxedes JN. Malignant hypertension with intestinal ischemia secondary to juxtaglomerular cell tumor. Am J Kidney Dis. 2005;46:957–61.

    Article  PubMed  Google Scholar 

  14. Kim HJ, Kim CH, Choi YJ, Ayala AG, Amirikachi M, Ro JY. Juxtaglomerular cell tumor of kidney with CD34 and CD117 immunoreactivity: report of 5 cases. Arch Pathol Lab Med. 2006;130:707–11.

    Article  PubMed  Google Scholar 

  15. Beaudoin J, Périgny M, Têtu B, Lebel M. A patient with a juxtaglomerular cell tumor with histological vascular invasion. Nat Clin Pr Nephrol. 2008;4:458–62.

    Article  Google Scholar 

  16. Gallery EDM, McGinn S, Fung C, Mahony JF. Curable hypertension. Hypertens Pregnancy. 2008;27:406–12.

    Article  CAS  PubMed  Google Scholar 

  17. Ossareh S, Shooshtarizadeh T, Shadpour P. A 22-year-old woman with hypertension and hypokalemia due to a juxtaglomerular cell tumor. Iran J Kidney Dis. 2011;5:425–8.

    PubMed  Google Scholar 

  18. Shin YS, Cha JS, Kang MJ, Park JK, Kim HJ, Kim MK. Newly developed hypertension due to juxtaglomerular cell tumor in pregnancy. Clin Nephrol. 2012;78:325–7.

    Article  PubMed  Google Scholar 

  19. Kuroda N, Maris S, Monzon FA, Tan PH, Thomas A, Petersson FB, et al. Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Hum Pathol. 2013;44:47–54.

    Article  CAS  PubMed  Google Scholar 

  20. Diker-Cohen T, Abraham SB, Rauschecker M, Papadakis GZ, Munir KM, Brown E, et al. Reninoma presenting in pregnancy. J Clin Endocrinol Metab. 2014;99:2625–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Prejbisz A, Antoniewicz AA, Kabat M, Kuroszczyk J, Stelmachowska-Banas M, Januszewicz A. Reninsecreting juxtaglomerular cell tumor of the kidney causing severe hypertension and polyuria. Pol Arch Med Wewn. 2014;124:207–8.

    PubMed  Google Scholar 

  22. Ohashi Y, Kobayashi S, Arai T, Nemoto T, Aoki C, Nagata M, et al. Focal segmental glomerulosclerosis secondary to juxtaglomerular cell tumor during pregnancy: a case report. Case Rep. Nephrol Urol. 2014;4:88–94.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Sierra JT, Rigo D, Arancibia A, Mukdsi J, Nicolai S, Ortiz ME. Juxtaglomerular cell tumour as a curable cause of hypertension: case presentation. Nefrologia. 2015;35:110–4.

    PubMed  Google Scholar 

  24. Prakash D. Target organ damage in newly detected hypertensive patients. J Fam Med Prim Care. 2019;8:2042–6.

    Article  Google Scholar 

  25. Elouazzani H, Jahid A, Bernoussi Z, Mahassini N. Juxtaglomerular cell tumor: a distinct mesenchymal tumor of kidney. J Clin Imaging Sci. 2014;4:33.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pedrinelli R, Graziadei L, Taddei S, Lenzi M, Magagna A, Bevilacqua G, et al. A renin-secreting tumor. Nephron. 1987;46:380–5.

    Article  CAS  PubMed  Google Scholar 

  27. Wong L, Hsu TH, Perlroth MG, Hofmann LV, Haynes CM, Katznelson L. Reninoma: case report and literature review. J Hypertens. 2008;26:368–73.

    Article  CAS  PubMed  Google Scholar 

  28. Trnka P, Orellana L, Walsh M, Pool L, Borzi P. Reninoma: an uncommon cause of Renin-mediated hypertension. Front Pediatr. 2014;2:89.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Feliciotti F, Campagnacci R, Perretta S, Paganini AM, Guerrieri M, Tamburini A, et al. Laparoscopic resection of a juxtaglomerular cell tumor of the right kidney. Surg Endosc. 2002;16:539.

    Article  CAS  PubMed  Google Scholar 

  30. Wang F, Shi C, Cui Y, Li C, Tong A. Juxtaglomerular cell tumor: clinical and immunohistochemical features. J Clin Hypertens (Greenwich). 2017;19:807–12.

    Article  CAS  PubMed  Google Scholar 

  31. Ye Z, Fan H, Tong A, Xiao Y, Zhang Y. The small size and superficial location suggest that laparoscopic partial nephrectomy is the first choice for the treatment of juxtaglomerular cell tumors. Front Endocrinol (Lausanne). 2021;12:646649.

    Article  PubMed  Google Scholar 

  32. Gordon RD, Wolfe LK, Island DP, Liddle GW. A diurnal rhythm in plasma renin activity in man. J Clin Invest. 1966;45:1587–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Baruch D, Corvol P, Alhenc-Gelas F, Dufloux MA, Guyenne TT, Gaux JC, et al. Diagnosis and treatment of renin-secreting tumors. Report of three cases. Hypertension. 1984;6:760–6.

    Article  CAS  PubMed  Google Scholar 

  34. Jędrusik P, Symonides B, Lewandowski J, Gaciong Z. The effect of antihypertensive medications on testing for primary aldosteronism. Front Pharm. 2021;12:684111.

    Article  Google Scholar 

  35. Conn JW, Cohen EL, McDonald WJ, Blough WM Jr., Lucas CP, Mayor GH, et al. The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism). J Urol. 1973;109:349–55.

    Article  CAS  PubMed  Google Scholar 

  36. Takahashi T, Miura T, Sue A, Saito K, Sakue M, Yamagata Y, et al. A case of juxtaglomerular cell tumor diagnosed preoperatively. Nephron. 1976;17:483–95.

    Article  CAS  PubMed  Google Scholar 

  37. Valdes G, Lopez JM, Martinez P, Rosenberg H, Barriga P, Rodriguez JA, et al. Renin-secreting tumor. Case Rep Hypertens. 1980;2:714–8.

    Article  CAS  Google Scholar 

  38. Dennis RL, McDougal WS, Glick AD, MacDonell RC Jr. Juxtaglomerular cell tumor of the kidney. J Urol. 1985;134:334–8.

    Article  CAS  PubMed  Google Scholar 

  39. Kida T, Takahashi T. Preoperative scintigraphic evaluation of the location of juxtaglomerular cell tumor. Eur J Nucl Med. 1985;10:382–5.

    Article  CAS  PubMed  Google Scholar 

  40. Lee BY, Song KS, Seo EJ, Cho EJ, Cho SY. Myocardial infarction in a young female with reninoma induced hypertension and myocardial bridging. Int J Cardiovasc Imaging. 2007;23:639–43.

    Article  PubMed  Google Scholar 

  41. Lin SY, Liu WY, Chen WC, Chen RH. Secondary hypertension due to a renin-secreting juxtaglomerular cell tumor. J Formos Med Assoc. 2010;109:237–40.

    Article  PubMed  Google Scholar 

  42. Venkateswaran R, Hamide A, Dorairajan LN, Basu D. Reninoma: a rare cause of curable hypertension. BMJ Case Rep. 2013. https://doi.org/10.1136/bcr-2012-008367.

  43. Wolley M, Gordon RD, Stowasser M. Reninoma: the importance of renal vein renin Ratios for lateralisation and diagnosis. Am J Nephrol. 2014;39:16–9.

    Article  CAS  PubMed  Google Scholar 

  44. Torricelli FC, Marchini GS, Colombo JR Jr., Coelho RF, Nahas WC, Srougi M. Nephron-sparing surgery for treatment of reninoma: a rare renin secreting tumor causing secondary hypertension. Int Braz J Urol. 2015;41:172–6.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kang S, Chen F, Zhong Y, Han B, Cheng G, Guo A, et al. Preoperative diagnosis of juxtaglomerular cell tumors in eight patients. J Clin Hypertens. 2016;18:982–90.

    Article  Google Scholar 

  46. Miyano G, Nagano C, Morita K, Yamoto M, Kaneshiro M, Miyake H, et al. A Case of Juxtaglomerular Cell Tumor, or Reninoma, of the Kidney Treated by Retroperitoneoscopy-Assisted Nephron-Sparing Partial Nephrectomy Through a Small Pararectal Incision. J Laparoendosc Adv Surg Tech A. 2016;26:235–8.

  47. Gupta S, Folpe AL, Torres-Mora J, Reuter VE, Zuckerman JE, Falk N, et al. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Hum Pathol. 2022;128:110–23.

    Article  CAS  PubMed  Google Scholar 

  48. Neyra JS, Medrano S, Goes Martini A, Sequeira-Lopez MLS, Gomez RA. The role of Gata3 in renin cell identity. Am J Physiol Ren Physiol. 2023;325:F188–98.

    Article  CAS  Google Scholar 

  49. Vidal-Petiot E, Bens M, Choudat L, Fernandez P, Rouzet F, Hermieu JF, et al. A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture. J Hypertens. 2015;33:1709–15.

    Article  CAS  PubMed  Google Scholar 

  50. Woo S, Cho JY. Imaging findings of common benign renal tumors in the era of small renal masses: Differential diagnosis from small renal cell carcinoma—current status and future perspectives. Korean J Radiol. 2015;16:99–113.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Faucon AL, Bourillon C, Grataloup C, Baron S, Bernadet-Monrozies P, Vidal-Petiot E, et al. Usefulness of magnetic resonance imaging in the diagnosis of juxtaglomerular cell tumors: a report of 10 cases and review of the literature. Am J Kidney Dis. 2018. https://doi.org/10.1053/j.ajkd.2018.09.005.

  52. ørjavik OS, Fauchald P, Hovig T, øystese B, Brodwall EK. Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies. Acta Med Scand. 1975;197:329–35.

    Article  PubMed  Google Scholar 

  53. Dunnick NR, Hartman DS, Ford KK, Davis CJ Jr, Amis ES Jr. The radiology of juxtaglomerular tumors. Radiology. 1983;147:321–6.

    Article  CAS  PubMed  Google Scholar 

  54. Agrawal R, Jafri SZH, Gibson DP, Bis KG, Ali-Reza A. Juxtaglomerular cell tumor: MR findings. J Comput Assist Tomogr. 1995;19:140–2.

    Article  CAS  PubMed  Google Scholar 

  55. Tanabe A, Naruse K, Kono A, Hase M, Hashimoto Y, Nakazawa H, et al. A very small juxtaglomerular cell tumor preoperatively identified by magnetic resonance imaging. Intern Med. 1996;35:295–300.

    Article  CAS  PubMed  Google Scholar 

  56. Ruyer A, Millet I, Ribstein J, Taourel P. [Renin-producing tumor: a rare case of curable hypertension. A case report]. J Radio. 2011;92:58–61.

    Article  CAS  Google Scholar 

  57. Kang S, Guo A, Wang H, Ma L, Xie Z, Li J, et al. Magnetic resonance imaging features of a juxtaglomerular cell tumor. J Clin Imaging Sci. 2015;5:68.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Warshaw BL, Anand SK, Olson DL, Grushkin CM, Heuser ET, Lieberman E. Hypertension secondary to a renin-producing juxtaglomerular cell tumor. J Pediatr. 1979;94:247–50.

    Article  CAS  PubMed  Google Scholar 

  59. Schambelan M, Howes EL Jr, Noakes CA, Biglieri EG. Role of renin and aldosterone in hypertension due to a renin-secreting tumor. Am J Med. 1973;55:86–92.

    Article  CAS  PubMed  Google Scholar 

  60. Bonnin JM, Cain MD, Jose JS, Mukherjee TM, Perrett LV, Scroop GC, et al. Hypertension due to a renin-secreting tumour localised by segmental renal vein sampling. Aust N Z J Med. 1977;7:630–5.

    Article  CAS  PubMed  Google Scholar 

  61. Connor G, Bennett CM, Lindstrom RR, Brosman SA, Barajas L, Edelbaum D. Juxtaglomerular cell tumor. Nephron. 1978;21:325–33.

    Article  CAS  PubMed  Google Scholar 

  62. Handa N, Fukunaga R, Yoneda S, Kimura K, Kamada T, Ichikawa Y, et al. State of systemic hemodynamics in a case of juxtaglomerular cell tumor. Clin Exp Hypertens A. 1986;8:1–19.

    CAS  PubMed  Google Scholar 

  63. Gordon RD, Tunny TJ, Klemm SA, Finn WL, Hawkins PJ, Hunyor SJ, et al. A renin-secreting tumour sensitive to changes in central blood volume (presumably via sympathetics) but not to circulating angiotensin II. Clin Exp Pharm Physiol. 1990;17:185–9.

    Article  CAS  Google Scholar 

  64. López GAJA, Blanco González J, Ortega Medina L, Sanz Esponera J. Juxtaglomerular cell tumor of the kidney. Morphological, immunohistochemical and ultrastructural studies of a new case. Pathol Res Pract. 1991;187:354–9.

    Google Scholar 

  65. Wang JH, Sheu MH, Lee RC. MR findings of renin-secreting tumor: a case report. Abdom Imaging. 1998;23:533–5.

    Article  CAS  PubMed  Google Scholar 

  66. Nicholson JP, Rayman G, Donaldson P, Driver IK. The anaesthetic management of a patient with a reninoma. Anaesthesia. 2003;58:466–70.

    Article  CAS  PubMed  Google Scholar 

  67. Daniele A, Sabbadin C, Costa G, Vezzaro R, Battistel M, Saraggi D, et al. A 10-year history of secondary hypertension: a challenging case of renin-secreting juxtaglomerular cell tumor. J Hypertens. 2018;36:1772–4.

    Article  CAS  PubMed  Google Scholar 

  68. Leemingsawat C, Thongtang N. Malignant hypertension due to a large reninoma: a case report. J Med Assoc Thai. 2012;95:S251–5.

    PubMed  Google Scholar 

  69. Chao CT, Chang FC, Wu VC, Chen JC, Taiwan Primary Aldosteronism Investigation Study G. Reninoma. Kidney Int. 2011;79:260.

    Article  PubMed  Google Scholar 

  70. Chao CT, Wu VC. Aliskiren for reninoma. Nephrology. 2012;17:308–9.

    Article  PubMed  Google Scholar 

  71. Gil NS, Han JY, Ok SH, Shin IW, Lee HK, Chung YK, et al. Anesthetic management for percutaneous computed tomography-guided radiofrequency ablation of reninoma: a case report. Korean J Anesthesiol. 2015;68:78–82.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Rosei CA, Giacomelli L, Salvetti M, Paini A, Corbellini C, Tiberio G, et al. Advantages of renin inhibition in a patient with reninoma. Int J Cardiol. 2015;187:240–2.

    Article  PubMed  Google Scholar 

  73. Okamura K, Takamiya Y, Mori K, Shirai K, Urata H. Add-on aliskiren treatment can decrease blood pressure but requires attention to risks of renal impairment and hyperkalemia Chikushi Anti-Hypertension Trial-Rasilez® (CHAT-Ras). Clin Exp Hypertens. 2020;42:545–52.

    Article  CAS  PubMed  Google Scholar 

  74. Reinhart M, Puil L, Salzwedel DM, Wright JM. First-line diuretics versus other classes of antihypertensive drugs for hypertension. Cochrane Database Syst Rev. 2023;7:Cd008161.

    PubMed  Google Scholar 

  75. Duan X, Bruneval P, Hammadeh R, Fresco R, Eble JN, Clark JI, et al. Metastatic juxtaglomerular cell tumor in a 52-year-old man. Am J Surg Pathol. 2004;28:1098–102.

    Article  PubMed  Google Scholar 

  76. Shera AH, Baba AA, Bakshi IH, Lone IA. Recurrent malignant juxtaglomerular cell tumor: a rare cause of malignant hypertension in a child. J Indian Assoc Pediatr Surg. 2011;16:152–4.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Cucchiari D, Bertuzzi A, Colombo P, De Sanctis R, Faucher E, Fusco N, et al. Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome. J Clin Oncol. 2013;31:e240–e242.

    Article  PubMed  Google Scholar 

  78. Munakata S, Tomiyama E, Takayama H. Case report of atypical juxtaglomerular cell tumor. Case Rep Pathol. 2018;2018:6407360.

    PubMed  PubMed Central  Google Scholar 

  79. Zhou J, Zheng S, Zhang Y, Yu Y, Zhou L, Zhang W, et al. Juxtaglomerular cell tumor: clinicopathologic evaluation in a large series emphasizing its broad histologic spectrum. Pathol Int. 2020;70:844–56.

    Article  CAS  PubMed  Google Scholar 

  80. Geisler D, Almutairi F, John I, Quiroga-Garza G, Yu M, Seethala R, et al. Malignant juxtaglomerular cell tumor. Urol Case Rep. 2022;45:102176.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Faucon AL, Bourillon C, Grataloup C, Baron S, Bernadet-Monrozies P, Vidal-Petiot E, et al. Usefulness of magnetic resonance imaging in the diagnosis of juxtaglomerular cell tumors: a report of 10 cases and review of the literature. Am J Kidney Dis. 2019;73:566–71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Hui Dong and Yujie Zuo: project development, data collection, manuscript writing. Xuanqi An and Yubao Zou: manuscript editing. Hongwu Li and Zhihao Zheng, and Yang Che: data analysis. Xiongjing Jiang: project development, manuscript editing.

Corresponding author

Correspondence to Xiongjing Jiang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval

This is an observational study. The Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College Research Ethics Committee has confirmed that no ethical approval is required

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, H., Zuo, Y., An, X. et al. Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review. Hypertens Res 47, 1380–1390 (2024). https://doi.org/10.1038/s41440-024-01606-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-024-01606-w

Keywords

Search

Quick links